Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission. Am J Hematol. 2016.
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?. Hematol Oncol. 2015..
Leukocyte Adhesion Deficiency -A Multicenter National Experience. Eur J Clin Invest. 2018:e13047..
Optimal therapeutic strategies for mixed phenotype acute leukemia. Curr Opin Hematol. 2020..